These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20356907)

  • 1. "Extraordinary Measures": Arrowsmith for the NASDAQ era.
    Weissmann G
    FASEB J; 2010 Apr; 24(4):963-7. PubMed ID: 20356907
    [No Abstract]   [Full Text] [Related]  

  • 2. Perspectives: biotechnology in Czech Republic, the past and the future.
    Damborský J; Prokop Z; Kostka M
    Biotechnol J; 2006 May; 1(5):487-90. PubMed ID: 16892283
    [No Abstract]   [Full Text] [Related]  

  • 3. An interview with Martin Rosenberg, Ph.D. Interviewed by Vicki Glaser.
    Rosenberg M
    Assay Drug Dev Technol; 2009 Dec; 7(6):537-43. PubMed ID: 20035618
    [No Abstract]   [Full Text] [Related]  

  • 4. Profile: John Maraganore. Interviewed by Brady Huggett.
    Maraganore J
    Nat Biotechnol; 2007 Apr; 25(4):375-6. PubMed ID: 17420733
    [No Abstract]   [Full Text] [Related]  

  • 5. Lessons from the past. Some members of the biotech class of 1982-83 reflect on the startup experience.
    Middleton A
    Biotechnology (N Y); 1993 Mar; 11(3):S40-3. PubMed ID: 7763434
    [No Abstract]   [Full Text] [Related]  

  • 6. Profile: Jean-Paul Clozel.
    Schmidt C
    Nat Biotechnol; 2007 Feb; 25(2):155. PubMed ID: 17287737
    [No Abstract]   [Full Text] [Related]  

  • 7. Profile: William Haseltine.
    Herrera S
    Nat Biotechnol; 2005 Aug; 23(8):913. PubMed ID: 16082351
    [No Abstract]   [Full Text] [Related]  

  • 8. Abe Abuchowski.
    Katsnelson A
    Nat Biotechnol; 2006 Sep; 24(9):1050. PubMed ID: 16964200
    [No Abstract]   [Full Text] [Related]  

  • 9. Venter's departure sees Celera seek therapies.
    Dennis C
    Nature; 2002 Jan; 415(6871):461. PubMed ID: 11823816
    [No Abstract]   [Full Text] [Related]  

  • 10. Profile: Una Ryan.
    Schmidt C
    Nat Biotechnol; 2006 Aug; 24(8):881. PubMed ID: 16900115
    [No Abstract]   [Full Text] [Related]  

  • 11. Profile: Jean Deleage.
    Ratner M
    Nat Biotechnol; 2005 Oct; 23(10):1197. PubMed ID: 16211047
    [No Abstract]   [Full Text] [Related]  

  • 12. The treatment: why is it so difficult to develop drugs for cancer?
    Gladwell M
    New Yorker; 2010 May; ():68-77. PubMed ID: 21692364
    [No Abstract]   [Full Text] [Related]  

  • 13. Mexico, the father of the pill and the race for cortisone.
    Renneberg R
    Biotechnol J; 2008 Apr; 3(4):449-51. PubMed ID: 18412173
    [No Abstract]   [Full Text] [Related]  

  • 14. Masters of their universe.
    Osborne R; DeFrancesco L
    Nat Biotechnol; 2009 Jun; 27(6):528-30. PubMed ID: 19513053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profile: Corey Goodman.
    Kling J
    Nat Biotechnol; 2009 Apr; 27(4):308. PubMed ID: 19352358
    [No Abstract]   [Full Text] [Related]  

  • 16. The socialite scientist.
    Serwer A
    Fortune; 2002 Apr; 145(8):152-4, 158, 160 passim. PubMed ID: 11961885
    [No Abstract]   [Full Text] [Related]  

  • 17. Profile: Thomas Lönngren.
    Louët S
    Nat Biotechnol; 2004 Nov; 22(11):1341. PubMed ID: 15529143
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmaceutical patent life-cycle management after KSR v. Teleflex.
    Furrow ME
    Food Drug Law J; 2008; 63(1):275-320. PubMed ID: 18561462
    [No Abstract]   [Full Text] [Related]  

  • 19. An early history of the molecular modeling industry.
    Richon AB
    Drug Discov Today; 2008 Aug; 13(15-16):659-64. PubMed ID: 18675760
    [No Abstract]   [Full Text] [Related]  

  • 20. Introduction: drug trajectories.
    Gaudillière JP
    Stud Hist Philos Biol Biomed Sci; 2005 Dec; 36(4):603-11. PubMed ID: 16337553
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.